The Prevalence of Heterozygous Familial Hypercholesterolemia among Adult Filipino Patients with Dyslipidemia at Universidad de Santa Isabel Health Services Department: An Observational Descriptive Prospective Study

نویسندگان

چکیده

Objectives: It is to determine the prevalence of familial hypercholesterolemia (FH) among adult Filipino patients with dyslipidemia at Universidad de Santa Isabel Health Services Department in one year. Methods: An observational descriptive prospective study involves patients, aged 19 years and older, dyslipidemia. The Dutch Lipid Network (DLN) Criteria was used diagnose FH. Prevalence data categorical variables were expressed as percentages, while continuous reported mean standard deviations. Results: 529 included study. 302 females, 227 males. 180 (34%) scored Unlikely, 100 (19%) Probable, 185 (35%) Possible, 64 (12%) classified under Definite Familial Hypercholesterolemia. Most diagnosed definite FH did not have diabetes, cerebrovascular disease (CVD), coronary artery (CAD). diagnosis affected by gender, BMI, smoking, alcohol consumption. Hypertension significantly correlated FH, most them already hypertensive diagnosis. noted that hypertension, CVD, CAD seen an earlier age Conclusion: heterozygous 12% 1.3% general population described for first time our region. This result should raise awareness healthcare providers which a major risk factor premature exists, early detection management are important.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Heterozygous Familial Hypercholesterolemia.

Familial hypercholesterolemia (FH) is a genetic condition that causes high low-density lipoprotein (LDL) cholesterol (sometimes referred to as bad cholesterol) from birth. FH means high cholesterol that runs in a family. FH is caused by specific DNA changes that are passed on from parents to their children. It is not caused by lifestyle factors such as a high-fat diet or lack of exercise. There...

متن کامل

Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.

We have evaluated the hypolipidemic effects of mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, the rate-limiting enzyme in cholesterol biosynthesis in 13 patients with heterozygous familial hypercholesterolemia (FH). Patients were maintained on a low-cholesterol diet and received sequentially increasing doses of 5, 10, 20, and 40 mg of mevinolin twice dail...

متن کامل

Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia

BACKGROUND The role of plasma cholesterol in impairing arterial function and elasticity remains unclear. We evaluated arterial stiffness, measured locally in the common carotid artery by high-resolution echo-tracking, and aortic stiffness, using carotid-femoral pulse wave velocity (PWV) (the "gold-standard" measurement of arterial stiffness), in treatment-naive patients with heterozygous famili...

متن کامل

Polyp prevalence at colonoscopy among Nigerians: A prospective observational study.

BACKGROUND This study was aimed at identifying the prevalence, distribution, and clinicopathologic characteristic of colonic polyps among Nigerians undergoing colonoscopy at the Obafemi Awolowo University Teaching Hospitals complex, Ile-Ife, Nigeria. We also determined the polyp detection rate (PDR), polyps per colonoscopy (PPC) and adenoma detection rate (ADR). MATERIALS AND METHODS This is ...

متن کامل

Genetic Analysis of Iranian Patients with Familial Hypercholesterolemia

Background: Familial hypercholesterolemia (FH) is a frequent autosomal dominant disorder of lipoprotein metabolism. This disorder is generally caused by mutations in low-density lipoprotein receptor (LDLR), apolipoprotein B 100 (APOB), and proprotein convertase subtilisin/kexin type 9 (PCSK9) genes. In the present study, we aimed at identifying the common LDLR and APOB gene mutations in an Iran...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: World Journal of Cardiovascular Diseases

سال: 2023

ISSN: ['2164-5329', '2164-5337']

DOI: https://doi.org/10.4236/wjcd.2023.137036